Federal contractor profile

EMERGENT BIOSOLUTIONS CANADA INC

UEI XM23STFMVML6CAGE L0EM2

Active

Overview

Legal name: EMERGENT BIOSOLUTIONS CANADA INC
Registered location: WINNIPEG, MB, CAN
Primary NAICS: 325414 — Biological Product (except Diagnostic) Manufacturing
Latest award activity: May 27, 2026

Read company summary

EMERGENT BIOSOLUTIONS CANADA INC is associated with UEI XM23STFMVML6 and CAGE L0EM2 in public federal records. AcornBids currently links 2 prime awards totaling $743.2M in obligations to this entity. Its largest recorded federal customer by obligations is Department of Health and Human Services. Its recorded federal awards include work classified as Pharmaceutical Preparation Manufacturing. These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 325414 (Biological Product (except Diagnostic) Manufacturing). Its public SAM.gov registration lists WINNIPEG, MB, CAN.

At a glance

Lifetime prime obligations$743.2M

Prime awards2

Awards with future end dates2

Top-agency concentration100.0%

Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Sep 28, 2026. Refresh pending; these totals may be out of date.

Business information

Public SAM.gov registration details.

Legal name: EMERGENT BIOSOLUTIONS CANADA INC
UEI: XM23STFMVML6
CAGE: L0EM2
Registered address: 155 INNOVATION DR, WINNIPEG, MB, R3T 5Y3, CAN
Registration status: Active
Primary NAICS: 325414 — Biological Product (except Diagnostic) Manufacturing
SAM activation: Sep 29, 2025
Initial registration: Jan 9, 2017
Entity start: Feb 22, 1984
SAM updated: Oct 2, 2025
Registration expires: Sep 25, 2026
Fiscal year end: Dec 31
Place of incorporation: CAN

View SAM.gov source

Federal award analysis

Net transaction obligations by federal fiscal period.

Transaction history is not available in the loaded data. Annual funding is not estimated from current award totals.

Recent federal awards

Prime contract awards. Select an award to review its history and source evidence.

Award / description	Awarding agency	Obligations	Start date	End date
75A50119C00075BOTULISM ANTITOXIN	Department of Health and Human Services	$320.9M	Sep 30, 2019	Mar 30, 2029
75A50119C00037VIGIV BUY AND ASSOCIATED SERVICES	Department of Health and Human Services	$422.3M	May 31, 2019	May 30, 2029

Explore, filter and export all awards →Subcontracts Grants & subgrants

Upcoming positioning windows

Modeled recompete windows are estimates, not announced solicitations or guarantees.

BOTULISM ANTITOXIN

Department of Health and Human Services$320.9M obligationsEnds Mar 30, 202960% recompete estimate

VIGIV BUY AND ASSOCIATED SERVICES

Department of Health and Human Services$422.3M obligationsEnds May 30, 202960% recompete estimate

Registration, certifications & contacts

Registration evidence	Date
SAM updated	Oct 2, 2025
Source loaded	Sep 26, 2026
Initial registration	Jan 9, 2017
Entity start	Feb 22, 1984

Industry	Reported size status
325414 — Biological Product (except Diagnostic) Manufacturing	Not reported
541714 — Research and Development in Biotechnology (except Nanobiotechnology)	Not reported

Contact	Role	Published contact methods	Evidence	Source date
REBECCA HEATH	Government business	Contact method not published	SAM registration	Not available
ALEX KONEV	Alternate government business	Contact method not published	SAM registration	Not available
REBECCA HEATH	Electronic business	Contact method not published	SAM registration	Not available
ALEX KONEV	Alternate electronic business	Contact method not published	SAM registration	Not available

Registered industries

325414 — Biological Product (except Diagnostic) Manufacturing
541714 — Research and Development in Biotechnology (except Nanobiotechnology)

Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source